← Leaderboards
Isabelle Rouiller
Univ Of Massachusetts Med Sch Worcester
$914,842
Attributed
$2,744,525
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $588K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,744,525 · 1
By mechanism
R01$2,744,525 · 1
Top collaborators
- Andres Finzi5 shared
- James B Munro5 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Shan Lu$23,520,369
- Andres Finzi$5,118,083
- Sharone Green$10,022,553
- Bo Wang$7,618,899
- Francis Anthony Ennis$2,726,792
Others in their field
Other Emerging Leaders on “Event”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Olwen Hahn · Brigham And Women'S Hospital$36,805,199
Research focus
EventAdoptionAffectAcquired Immunodeficiency SyndromeAntibody ActivationAntibody-Dependent Cell CytotoxicityAntigensAntiretroviral TherapyAdoptedBindingBinding SitesBone DiseasesCardiovascular DiseasesCellsCharacteristicsComorbidityCryoelectron MicroscopyDesignElementsAntibodiesEnzyme-Linked Immunosorbent AssayEpidemicEpitopesFluorescence Imaging
Grant awards (5)
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$541,156
R01 · FY2024 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$538,456
R01 · FY2023 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$540,616
R01 · FY2022 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$536,296
R01 · FY2021 · AI
Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies$588,001
R01 · FY2020 · AI